Published in Dalton Trans on January 21, 2005
NH NMR shifts of new structurally characterized fac-[Re(CO)3(polyamine)]n+ complexes probed via outer-sphere hydrogen-bonding interactions to anions, including the paramagnetic [Re(IV)Br6]2- anion. Inorg Chem (2010) 0.86
Formation of a metal-to-nitrogen bond of normal length by a neutral sufonamide group within a tridentate ligand. A new approach to radiopharmaceutical bioconjugation. Inorg Chem (2013) 0.81
Complexes possessing rare "tertiary" sulfonamide nitrogen-to-metal bonds of normal length: fac-[Re(CO)3(N(SO2R)dien)]PF6 complexes with hydrophilic sulfonamide ligands. Inorg Chem (2014) 0.78
Synthesis, characterization and reactivity of carbohydrate platinum(IV) complexes with thioglycoside ligands. Dalton Trans (2010) 0.75
Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorin. Mol Cancer Ther (2014) 2.10
Metal complexes in medicinal chemistry: new vistas and challenges in drug design. Dalton Trans (2005) 1.61
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry (2010) 1.45
Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev (2009) 1.30
Vanadium in diabetes: 100 years from Phase 0 to Phase I. J Inorg Biochem (2006) 1.28
Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J Am Chem Soc (2008) 1.28
Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem (2008) 1.27
Arylfluoroborates and alkylfluorosilicates as potential PET imaging agents: high-yielding aqueous biomolecular 18F-labeling. J Am Chem Soc (2005) 1.23
Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev (2013) 1.20
Syntheses, structural characterization and photophysical properties of 4-(2-pyridyl)-1,2,3-triazole rhenium(I) complexes. Dalton Trans (2008) 1.20
Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. Dalton Trans (2008) 1.10
Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc (2007) 1.10
Substituent effects on aryltrifluoroborate solvolysis in water: implications for Suzuki-Miyaura coupling and the design of stable (18)F-labeled aryltrifluoroborates for use in PET imaging. J Org Chem (2008) 1.06
Carbohydrate-appended 2,2'-dipicolylamine metal complexes as potential imaging agents. Inorg Chem (2005) 1.05
Metal complexes of maltol and close analogues in medicinal inorganic chemistry. Chem Soc Rev (2006) 1.05
Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). Inorg Chem (1997) 1.04
Imaging of enzyme replacement therapy using PET. Proc Natl Acad Sci U S A (2010) 1.03
Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol. Inorg Chem (1996) 1.02
Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed Engl (2007) 1.01
Boon and bane of metal ions in medicine. Science (2003) 0.99
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. Clin Cancer Res (2008) 0.99
Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. J Inorg Biochem (2004) 0.98
Metallodrugs in medicinal inorganic chemistry. Chem Rev (2014) 0.97
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. J Am Chem Soc (2005) 0.96
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Trans (2008) 0.95
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. J Biol Inorg Chem (2002) 0.94
Design of targeting ligands in medicinal inorganic chemistry. Chem Soc Rev (2006) 0.94
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J Inorg Biochem (2004) 0.93
Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates. Inorg Chem (2006) 0.93
Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer. Cancer Res (2010) 0.93
Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III). Bioconjug Chem (2005) 0.93
Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration. J Am Chem Soc (2010) 0.93
Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers. Inorg Chem (2005) 0.92
Tetrakis(2-quinolinylmethyl)ethylenediamine (TQEN) as a new fluorescent sensor for zinc. Dalton Trans (2004) 0.92
Bis(ligand) Rhenium(V) and Technetium(V) Complexes of Two Naturally Occurring Binding Moieties (Oxazoline and Thiazoline). Inorg Chem (1996) 0.92
Werner coordination chemistry and neurodegeneration. Chem Soc Rev (2012) 0.92
Stoichiometric leverage: rapid 18F-aryltrifluoroborate radiosynthesis at high specific activity for click conjugation. Angew Chem Int Ed Engl (2013) 0.92
Tumour targeting with radiometals for diagnosis and therapy. Chem Commun (Camb) (2013) 0.91
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorg Chem (2012) 0.91
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. Dalton Trans (2014) 0.91
Carbohydrate conjugates for molecular imaging and radiotherapy: 99mTc(I) and 186Re(I) tricarbonyl complexes of N-(2'-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. Bioconjug Chem (2004) 0.90
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J Inorg Biochem (2005) 0.90
RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Nucl Med Biol (2012) 0.89
Testis-specific HMG-domain protein alters the responses of cells to cisplatin. J Inorg Biochem (2002) 0.89
H4octapa: an acyclic chelator for 111In radiopharmaceuticals. J Am Chem Soc (2012) 0.88
In vitro heavy-atom effect of palladium(II) and platinum(II) complexes of pyrrolidine-fused chlorin in photodynamic therapy. J Med Chem (2009) 0.88
Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin. Dalton Trans (2015) 0.88
Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer. Anticancer Res (2011) 0.87
New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake. Nucl Med Biol (2011) 0.87
Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core. Inorg Chem (2008) 0.86
Synthesis and photocytotoxicity of S-glucosylated 5,10,15,20-Tetrakis(tetrafluorophenyl)porphyrin metal complexes as efficient (1)O(2)-generating glycoconjugates. Bioconjug Chem (2009) 0.86
Cellular uptake and photocytotoxicity of glycoconjugated chlorins in HeLa cells. J Photochem Photobiol B (2005) 0.86
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomography. BJU Int (2007) 0.86
Synthesis, photophysical properties and sugar-dependent in vitro photocytotoxicity of pyrrolidine-fused chlorins bearing S-glycosides. J Photochem Photobiol B (2009) 0.85
Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry. Dalton Trans (2009) 0.85
Evaluation of the H2)dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu. Inorg Chem (2012) 0.85
Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats. Mol Cell Biochem (2002) 0.84
Synthesis and structure of novel sugar-substituted bipyridine complexes of rhenium and 99m-technetium. Chemistry (2007) 0.84
Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells. BMC Cancer (2013) 0.83
Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies. Inorg Chem (2005) 0.83
Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Photochem Photobiol (2010) 0.83
Cationic Lanthanide Complexes of N,N'-Bis(2-pyridylmethyl)ethylenediamine-N,N'-diacetic Acid (H(2)bped). Inorg Chem (1997) 0.83
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Trans (2009) 0.83
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. J Am Chem Soc (2013) 0.83
Age and severity of nigrostriatal damage at onset of Parkinson's disease. Synapse (2003) 0.82
Sugar-dependent aggregation of glycoconjugated chlorins and its effect on photocytotoxicity in HeLa cells. J Photochem Photobiol B (2006) 0.81
Cellular uptake and photocytotoxicity of glycoconjugated porphyrins in HeLa cells. Photochem Photobiol (2004) 0.81
H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals. Inorg Chem (2015) 0.81
Vanadium compounds in the treatment of diabetes. Met Ions Biol Syst (2004) 0.81
A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disord (2005) 0.80
Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. J Inorg Biochem (2008) 0.80
Studies of the mechanism of the in-loop synthesis of radiopharmaceuticals. Appl Radiat Isot (2004) 0.80
Methoxy-substituted TQEN family of fluorescent zinc sensors. Inorg Chem (2006) 0.80
Theoretical studies of the tautomers of pyridinethiones. J Phys Chem A (2008) 0.80
Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit. Bioorg Med Chem Lett (2004) 0.79
Structural, Spectroscopic, Thermodynamic and Kinetic Properties of Copper(II) Complexes with Tripodal Tetraamines. Inorg Chem (1998) 0.79
One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co. Dalton Trans (2011) 0.79
Diamagnetic-paramagnetic conversion of tris(2-pyridylthio)methylcopper(III) through a structural change from trigonal bipyramidal to octahedral. Angew Chem Int Ed Engl (2006) 0.79